dei |
Entity Common Stock, Shares Outstanding |
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
View
|
us-gaap |
Accounts Payable, Current |
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Accounts Receivable, after Allowance for Credit Loss, Current |
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
View
|
us-gaap |
Additional Paid in Capital |
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
View
|
us-gaap |
Advertising Expense |
Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. |
View
|
us-gaap |
Assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Assets, Current |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Cash and Cash Equivalents, at Carrying Value |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash, Period Increase (Decrease) |
Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes. |
View
|
us-gaap |
Common Stock, Shares Authorized |
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Common Stock, Shares, Issued |
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
View
|
us-gaap |
Common Stock, Shares, Outstanding |
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. |
View
|
us-gaap |
Common Stock, Value, Issued |
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
View
|
us-gaap |
Cost of Goods and Services Sold |
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
View
|
us-gaap |
Deferred Tax Assets, Operating Loss Carryforwards |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. |
View
|
us-gaap |
Deferred Tax Assets, Valuation Allowance |
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. |
View
|
us-gaap |
Earnings Per Share, Basic and Diluted |
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Percent |
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Deduction, Percent |
Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. |
View
|
us-gaap |
Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) |
Percentage of revenue generated from a single external customer that accounts for 10 percent or more of an entity's revenues. |
View
|
us-gaap |
General and Administrative Expense |
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
View
|
us-gaap |
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent |
Amount after tax of income (loss) from continuing operations attributable to the parent. |
View
|
us-gaap |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
View
|
us-gaap |
Increase (Decrease) in Accounts Payable |
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
View
|
us-gaap |
Increase (Decrease) in Accounts Receivable |
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
View
|
us-gaap |
Increase (Decrease) in Income Taxes Payable |
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
View
|
us-gaap |
Liabilities and Equity |
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
View
|
us-gaap |
Liabilities, Current |
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
View
|
us-gaap |
Net Cash Provided by (Used in) Financing Activities |
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
View
|
us-gaap |
Net Cash Provided by (Used in) Operating Activities |
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. |
View
|
us-gaap |
Operating Loss Carryforwards |
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. |
View
|
us-gaap |
Payments to Acquire in Process Research and Development |
The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. |
View
|
us-gaap |
Proceeds from Issuance of Private Placement |
The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
View
|
us-gaap |
Professional Fees |
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. |
View
|
us-gaap |
Research and Development Expense |
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. |
View
|
us-gaap |
Retained Earnings (Accumulated Deficit) |
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
View
|
us-gaap |
Revenues |
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
View
|
us-gaap |
Share-based Payment Arrangement, Noncash Expense |
Amount of noncash expense for share-based payment arrangement. |
View
|
us-gaap |
Shares, Issued |
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. |
View
|
us-gaap |
Stockholders' Equity Attributable to Parent |
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
View
|
us-gaap |
Stock Issued During Period, Shares, Employee Stock Ownership Plan |
Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan. |
View
|
us-gaap |
Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) |
Number of shares issued as consideration for cash for development stage entities. |
View
|
us-gaap |
Stock Issued During Period, Shares, Issued for Services |
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. |
View
|
us-gaap |
Stock Issued During Period, Value, New Issues |
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
View
|
us-gaap |
Stock Issued During Period, Value, Other |
Value of shares of stock issued attributable to transactions classified as other. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Diluted |
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. |
View
|
us-gaap |
Common Stock, Par or Stated Value Per Share |
Face amount or stated value per share of common stock. |
View
|
us-gaap |
Net Income (Loss) Attributable to Parent |
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
View
|